Number of the records: 1
Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein
- 1.
SYSNO ASEP 0560439 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Beneficial Effects of Empagliflozin Are Mediated by Reduced Renal Inflammation and Oxidative Stress in Spontaneously Hypertensive Rats Expressing Human C-Reactive Protein Author(s) Malínská, H. (CZ)
Hüttl, M. (CZ)
Marková, I. (CZ)
Miklánková, D. (CZ)
Hojná, Silvie (FGU-C) RID, ORCID
Papoušek, František (FGU-C)
Šilhavý, Jan (FGU-C) RID, ORCID
Mlejnek, Petr (FGU-C) RID, ORCID
Zicha, Josef (FGU-C) RID, ORCID, SAI
Hrdlička, Jaroslav (FGU-C) ORCID, RID
Pravenec, Michal (FGU-C) RID, ORCID
Vaněčková, Ivana (FGU-C) RID, ORCIDArticle number 2066 Source Title Biomedicines. - : MDPI
Roč. 10, č. 9 (2022)Number of pages 15 s. Language eng - English Country CH - Switzerland Keywords SHR-CRP ; SGLT-2 inhibitor ; gene expression ; age ; lipid metabolism OECD category Physiology (including cytology) R&D Projects GA19-06199S GA ČR - Czech Science Foundation (CSF) LX22NPO5104 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) Method of publishing Open access Institutional support FGU-C - RVO:67985823 UT WOS 000859391100001 EID SCOPUS 85138637206 DOI 10.3390/biomedicines10092066 Annotation Gliflozins (inhibitors of sodium-glucose cotransporter 2) show many beneficial actions beyond their antidiabetic effects. The underlying mechanisms of these additional protective effects are still not well understood, especially under non-diabetic conditions. Therefore, we analyzed the effects of empagliflozin in young (3-month-old) and adult (12-month-old) male spontaneously hypertensive rats (SHR) expressing human C-reactive protein (CRP) in the liver. SHR-CRP rats are a non-diabetic model of metabolic syndrome, inflammation, and organ damage. Empagliflozin was given in a daily dose of 10 mg/kg body weight for 8 weeks. Both age groups of SHR-CRP rats treated with empagliflozin had lower body weight, decreased weight of fat depots, reduced ectopic fat accumulation in the liver and kidneys, and decreased levels of plasma insulin and beta-hydroxybutyrate. Empagliflozin effectively reduced ectopic renal fat accumulation, and was associated with decreased inflammation. Exclusively in young rats, decreased microalbuminuria after empagliflozin treatment was accompanied by attenuated oxidative stress. In adult animals, empagliflozin also improved left ventricle function. In conclusion, in young animals, the beneficial renoprotective effects of empagliflozin could be ascribed to reduced lipid deposition in the kidney and the attenuation of oxidative stress and inflammation. In contrast, hepatic lipid metabolism was ameliorated in adult rats. Workplace Institute of Physiology Contact Lucie Trajhanová, lucie.trajhanova@fgu.cas.cz, Tel.: 241 062 400 Year of Publishing 2023 Electronic address https://www.mdpi.com/2227-9059/10/9/2066
Number of the records: 1